Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
-
Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference
-
Adicet Bio to Participate in a Fireside Chat at the Canaccord Genuity 43rd Annual Growth Conference
-
Adicet Bio to Participate in 2023 Canaccord Genuity Horizons in Oncology Virtual Conference
-
Adicet Bio to Present at Upcoming Investor Conferences
-
Adicet Bio to Participate in Upcoming Investor Conferences
-
Adicet Bio to Participate in Upcoming Investor Conferences
-
Adicet Bio to Participate in Upcoming Investor Conferences
-
Adicet Bio to Participate in the Canaccord Genuity 2021 Horizons in Oncology Virtual Conference
-
Adicet Bio to Participate in the Canaccord Genuity 2021 Horizons in Oncology Virtual Conference
-
Adicet Bio, Inc. Announces Closing of $152 Million Public Offering and Concurrent Private Placement and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
-
Adicet Bio, Inc. Announces Closing of $152 Million Public Offering and Concurrent Private Placement and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
-
ACETO Corp (ACET) Prices 9.23M Share Common Offering at $13/Sh; Announces Concurrent Private Placement
-
Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent Private Placement
-
Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent Private Placement
-
Canaccord Genuity Double Downgrades Aceto Corp. (ACET) to Sell
-
Aceto Corp. (ACET) PT Lowered to $13 at Canaccord Genuity
-
Canaccord Genuity Starts Aceto Corp. (ACET) at Buy
